Your browser doesn't support javascript.
loading
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
Muskiet, Marcel H A; Tonneijck, Lennart; Smits, Mark M; van Baar, Michaël J B; Kramer, Mark H H; Hoorn, Ewout J; Joles, Jaap A; van Raalte, Daniël H.
Afiliação
  • Muskiet MHA; Diabetes Center, Department of Internal Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
  • Tonneijck L; Diabetes Center, Department of Internal Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
  • Smits MM; Diabetes Center, Department of Internal Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
  • van Baar MJB; Diabetes Center, Department of Internal Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
  • Kramer MHH; Diabetes Center, Department of Internal Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
  • Hoorn EJ; Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE, Rotterdam, Netherlands.
  • Joles JA; Department of Nephrology and Hypertension, University Medical Centre, Heidelberglaan 100, 3584 CX, Utrecht, Netherlands.
  • van Raalte DH; Diabetes Center, Department of Internal Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
Nat Rev Nephrol ; 13(10): 605-628, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28869249

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Peptídeo 1 Semelhante ao Glucagon / Inibidores da Dipeptidil Peptidase IV / Incretinas / Hiperglicemia / Hipoglicemiantes Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Peptídeo 1 Semelhante ao Glucagon / Inibidores da Dipeptidil Peptidase IV / Incretinas / Hiperglicemia / Hipoglicemiantes Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article